| Literature DB >> 28366650 |
Katharina F Hermann1, Claudia S Neuhaus1, Virgine Micallef2, Björn Wagner2, Maja Hatibovic1, Hélène E Aschmann1, Franziska Paech1, Rubén Alvarez-Sanchez2, Stefanie D Krämer3, Sara Belli4.
Abstract
For low molecular weight drugs, lipid bilayer permeation is considered the major route for in vivo cell barrier passage. We recently introduced a fluorescence assay with liposomes to determine permeation kinetics of ionisable compounds across the lipid bilayer by monitoring drug-induced pH changes inside the liposomes. Here, we determined the permeability coefficients (PFLipP, FLipP for "Fluorescence Liposomal Permeability") across 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayers of 35 ionisable drugs at pH6.0 and compared them to available in vivo human jejunal permeability (Peff) data. PFLipP values were furthermore compared with published Caco-2 cell permeability coefficients (PCaco-2), permeability coefficients determined with the parallel artificial membrane permeability assay (PAMPA) and with log D (pH6.0). The log PFLipP, corrected for predicted para-cellular diffusion, and log PCaco-2 correlated best with log Peff, with similar adjusted R2 (0.75 and 0.74, n=12). Our results suggest that transporter-independent intestinal drug absorption is predictable from liposomal permeability.Entities:
Keywords: Caco-2; FLipP; Fluorescence; Intestinal absorption; Liposomes; Permeability
Mesh:
Substances:
Year: 2017 PMID: 28366650 DOI: 10.1016/j.ejps.2017.03.040
Source DB: PubMed Journal: Eur J Pharm Sci ISSN: 0928-0987 Impact factor: 4.384